Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy

Saved in:
Bibliographic Details
Published inJAAD Case Reports Vol. 4; no. 2; pp. 129 - 131
Main Authors Reinhard, Raphael, Gebhardt, Christoffer, Maurier, Nolwenn, Larribère, Lionel, Orouji, Azadeh, Utikal, Jochen
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2018
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Author Orouji, Azadeh
Reinhard, Raphael
Larribère, Lionel
Gebhardt, Christoffer
Maurier, Nolwenn
Utikal, Jochen
AuthorAffiliation a Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
b Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany
AuthorAffiliation_xml – name: b Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany
– name: a Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
Author_xml – sequence: 1
  givenname: Raphael
  surname: Reinhard
  fullname: Reinhard, Raphael
  email: raphael.reinhard@umm.de
  organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
– sequence: 2
  givenname: Christoffer
  surname: Gebhardt
  fullname: Gebhardt, Christoffer
  organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
– sequence: 3
  givenname: Nolwenn
  surname: Maurier
  fullname: Maurier, Nolwenn
  organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
– sequence: 4
  givenname: Lionel
  surname: Larribère
  fullname: Larribère, Lionel
  organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
– sequence: 5
  givenname: Azadeh
  surname: Orouji
  fullname: Orouji, Azadeh
  organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
– sequence: 6
  givenname: Jochen
  surname: Utikal
  fullname: Utikal, Jochen
  organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29387762$$D View this record in MEDLINE/PubMed
BookMark eNp9kW9rFDEQxoNUbK39Ar6Q_QK35u8mARFqabXYIoi-E8JsMnuXZW-zZPcO-u3NeVraN0Jghsw8v8zkeU1OxjQiIW8ZrRllzfu-7oPPNadM19TWlOoX5IwLxVeK8ebkSX5KLua5p5QyJbXQ7BU55VYYrRt-Rn7d74YlTgNWOMWAeZuWnKboqy0OMKYtlGSBuRycq4B7HEp1XFdhlw_h0_fLmwrGUN1ff63iuIltXFKulg1mmB7ekJcdDDNe_I3n5OfN9Y-rL6u7b59vry7vVl6UkVaNkY1RQVpACYprMEZyKzVjVlJugNEuKI3edLq1rVaqtULSFrhpmbQCxDm5PXJDgt5NOW4hP7gE0f25SHntIC_RD-iEQegQLBoGMhgBFBvftA0GrUTQurA-HlnTrt1i8DguGYZn0OeVMW7cOu2d0sYqzgqAHwE-p3nO2D1qGXUH61zvDta5g3WOWlesK6J3T199lPwzqjR8ODZg-cd9xOxmH3H0GGJGv5RF4__4vwHfJa1q
Cites_doi 10.1056/NEJMoa1406037
10.1016/j.advms.2014.12.002
10.1097/CMR.0000000000000332
10.1016/S1470-2045(16)30122-X
10.1016/S0140-6736(15)60898-4
10.1097/DSS.0000000000000251
10.1111/j.1365-2133.2006.07333.x
10.1016/j.ejca.2016.02.023
10.1097/DAD.0b013e3181b34a19
ContentType Journal Article
Copyright 2017 American Academy of Dermatology, Inc.
2017 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2017 American Academy of Dermatology, Inc.
Copyright_xml – notice: 2017 American Academy of Dermatology, Inc.
– notice: 2017 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2017 American Academy of Dermatology, Inc.
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
5PM
DOA
DOI 10.1016/j.jdcr.2017.09.007
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2352-5126
EndPage 131
ExternalDocumentID oai_doaj_org_article_38eafea9e81a4d83a0e6c6b6ed753d77
10_1016_j_jdcr_2017_09_007
29387762
S2352512617302138
Genre Case Reports
GroupedDBID .1-
.FO
0R~
0SF
1P~
4.4
457
53G
5VS
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AALRI
AAXUO
ABMAC
ACGFS
ADBBV
ADEZE
AEXQZ
AFCTW
AFRHN
AFTJW
AGHFR
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
IPNFZ
IXB
KQ8
M41
M~E
NCXOZ
O9-
OK1
RIG
ROL
RPM
SSZ
Z5R
AKRWK
NPM
AAYXX
ADVLN
CITATION
5PM
ID FETCH-LOGICAL-c3547-684685d49ae4a527a88429471194028a10fd57ec8f7b9b755b9340ba28b1493a3
IEDL.DBID RPM
ISSN 2352-5126
IngestDate Thu Jul 04 21:05:14 EDT 2024
Tue Sep 17 21:34:29 EDT 2024
Fri Aug 23 00:42:43 EDT 2024
Thu May 23 23:52:27 EDT 2024
Wed May 17 01:04:45 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords metastases
targeted therapy
melanoma
MEK
BRAF
Language English
License This is an open access article under the CC BY-NC-ND license.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3547-684685d49ae4a527a88429471194028a10fd57ec8f7b9b755b9340ba28b1493a3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789521/
PMID 29387762
PageCount 3
ParticipantIDs doaj_primary_oai_doaj_org_article_38eafea9e81a4d83a0e6c6b6ed753d77
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5789521
crossref_primary_10_1016_j_jdcr_2017_09_007
pubmed_primary_29387762
elsevier_sciencedirect_doi_10_1016_j_jdcr_2017_09_007
PublicationCentury 2000
PublicationDate 2018-03-01
PublicationDateYYYYMMDD 2018-03-01
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAAD Case Reports
PublicationTitleAlternate JAAD Case Rep
PublicationYear 2018
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Roesch, Paschen, Landsberg, Helfrich, Becker, Schadendorf (bib5) 2016; 59
Van Jarwaarde, Wessels, Nieweg, Wouters, van der Hage (bib9) 2015; 41
Ascierto, McArthur, Dréno (bib1) 2016; 17
Long, Stroyakovskiy, Gogas (bib3) 2014; 371
Tas, Erturk (bib6) 2017; 27
Utikal, Zimpfer, Thoelke (bib8) 2006; 155
Stadler, Weina, Gebhardt, Utikal (bib4) 2015; 60
Plaza, Torres-Cabala, Evans, Diwan, Suster, Prieto (bib7) 2010; 32
Long, Stroyakovskiy, Gogas (bib2) 2015; 386
Tas (10.1016/j.jdcr.2017.09.007_bib6) 2017; 27
Ascierto (10.1016/j.jdcr.2017.09.007_bib1) 2016; 17
Plaza (10.1016/j.jdcr.2017.09.007_bib7) 2010; 32
Stadler (10.1016/j.jdcr.2017.09.007_bib4) 2015; 60
Utikal (10.1016/j.jdcr.2017.09.007_bib8) 2006; 155
Roesch (10.1016/j.jdcr.2017.09.007_bib5) 2016; 59
Long (10.1016/j.jdcr.2017.09.007_bib2) 2015; 386
Long (10.1016/j.jdcr.2017.09.007_bib3) 2014; 371
Van Jarwaarde (10.1016/j.jdcr.2017.09.007_bib9) 2015; 41
References_xml – volume: 41
  start-page: 78
  year: 2015
  end-page: 82
  ident: bib9
  article-title: CO2 laser treatment for regional cutaneous malignant melanoma metastases
  publication-title: Dermatol Surg
  contributor:
    fullname: van der Hage
– volume: 371
  start-page: 1877
  year: 2014
  end-page: 1888
  ident: bib3
  article-title: Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
  publication-title: N Engl J Med
  contributor:
    fullname: Gogas
– volume: 386
  start-page: 444
  year: 2015
  end-page: 451
  ident: bib2
  article-title: Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
  publication-title: Lancet
  contributor:
    fullname: Gogas
– volume: 155
  start-page: 488
  year: 2006
  end-page: 491
  ident: bib8
  article-title: Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod
  publication-title: Br J Dermatol
  contributor:
    fullname: Thoelke
– volume: 60
  start-page: 83
  year: 2015
  end-page: 88
  ident: bib4
  article-title: New therapeutic options for advanced non-resectable malignant melanoma
  publication-title: Adv Med Sci
  contributor:
    fullname: Utikal
– volume: 27
  start-page: 134
  year: 2017
  end-page: 139
  ident: bib6
  article-title: Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors
  publication-title: Melanoma Res
  contributor:
    fullname: Erturk
– volume: 17
  start-page: 1248
  year: 2016
  end-page: 1260
  ident: bib1
  article-title: Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
  publication-title: Lancet Oncol
  contributor:
    fullname: Dréno
– volume: 59
  start-page: 109
  year: 2016
  end-page: 112
  ident: bib5
  article-title: Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
  publication-title: Eur J Cancer
  contributor:
    fullname: Schadendorf
– volume: 32
  start-page: 129
  year: 2010
  end-page: 136
  ident: bib7
  article-title: Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum
  publication-title: Am J Dermatopathol
  contributor:
    fullname: Prieto
– volume: 371
  start-page: 1877
  issue: 20
  year: 2014
  ident: 10.1016/j.jdcr.2017.09.007_bib3
  article-title: Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1406037
  contributor:
    fullname: Long
– volume: 60
  start-page: 83
  issue: 1
  year: 2015
  ident: 10.1016/j.jdcr.2017.09.007_bib4
  article-title: New therapeutic options for advanced non-resectable malignant melanoma
  publication-title: Adv Med Sci
  doi: 10.1016/j.advms.2014.12.002
  contributor:
    fullname: Stadler
– volume: 27
  start-page: 134
  issue: 2
  year: 2017
  ident: 10.1016/j.jdcr.2017.09.007_bib6
  article-title: Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors
  publication-title: Melanoma Res
  doi: 10.1097/CMR.0000000000000332
  contributor:
    fullname: Tas
– volume: 17
  start-page: 1248
  issue: 9
  year: 2016
  ident: 10.1016/j.jdcr.2017.09.007_bib1
  article-title: Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(16)30122-X
  contributor:
    fullname: Ascierto
– volume: 386
  start-page: 444
  issue: 9992
  year: 2015
  ident: 10.1016/j.jdcr.2017.09.007_bib2
  article-title: Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60898-4
  contributor:
    fullname: Long
– volume: 41
  start-page: 78
  issue: 1
  year: 2015
  ident: 10.1016/j.jdcr.2017.09.007_bib9
  article-title: CO2 laser treatment for regional cutaneous malignant melanoma metastases
  publication-title: Dermatol Surg
  doi: 10.1097/DSS.0000000000000251
  contributor:
    fullname: Van Jarwaarde
– volume: 155
  start-page: 488
  issue: 2
  year: 2006
  ident: 10.1016/j.jdcr.2017.09.007_bib8
  article-title: Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2006.07333.x
  contributor:
    fullname: Utikal
– volume: 59
  start-page: 109
  year: 2016
  ident: 10.1016/j.jdcr.2017.09.007_bib5
  article-title: Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2016.02.023
  contributor:
    fullname: Roesch
– volume: 32
  start-page: 129
  issue: 2
  year: 2010
  ident: 10.1016/j.jdcr.2017.09.007_bib7
  article-title: Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum
  publication-title: Am J Dermatopathol
  doi: 10.1097/DAD.0b013e3181b34a19
  contributor:
    fullname: Plaza
SSID ssj0001547371
Score 2.0759823
SourceID doaj
pubmedcentral
crossref
pubmed
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 129
SubjectTerms BRAF
MEK
melanoma
metastases
targeted therapy
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-wwFA7iQtyIz-tcH2ThToptkzTJUsVBlHEhCi6EcPIoVq4dGecu_PeeNB2dgYt34660pUnP1_R8HzkPQo68UtxWHmVJ6VzGRe4yQFae5VCBLSzLXRnznUc31eU9v3oQD3OtvmJMWCoPnAx3wlSAOoAOqgDuFYM8VK6yVfBItL1MeeSFmBNTKT-YS9aprRIZRoZereozZlJw17N3sRhoIbsip7GX7JxX6or3_9s5LQZOznmi4TpZ6ykkPU1T3yBLod0kK6N-k3yLPI76IEEaYvvXCYIxGb82jr6EP9COXwAPpoCs8C280a-kKZoyFunZ7emQQuvp6OKaNu1TY3HRT2hK1HrfJvfDi7vzy6xvopA5hkbIKiQYSniuIXAQpQQEp9TokgqN0lFBkddeyOBULa22UgirGc8tlMqieGLAdshyO27DLqGy1qj2XFFbiEqLWY1L1gN3KDtC4dmAHM-MaF5TrQwzCyJ7NtHkJprc5NqgyQfkLNr5885Y57o7geibHn3zP_QHRMxQMj1lSFQAH9V8O_ivhOTn8Eh7lETPMCByAeOF-S1eaZunrh43_vQ0sqDfP_FCe2QVp6lSlNs-WZ5O_oYDpD1Te9h94R8BNQAT
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ScienceDirect Free and Delayed Access Journal
  dbid: IXB
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh6qXij4oS2nlQ29VtEmcxPaRRaxQq-2hLdIekKzxIyWIza7C9tB_z0ziBSJVHHpLHMe2Zux5JDPfMPbZK1XYyqNbkjuXFGXqEkCrPEmhAptZkbqc8p0X36uLy-LrslzusbNdLgyFVUbZP8j0XlrHlmmk5nTTNNOfOSF5ZoQoLlBRCUr4pRZK4lvOHr-zUHHd3u-i_gm9EHNnhjCvG-8IFjSTPdwpVZV9op96GP9_q6lxCOUTnTQ_YK-iMclPh_W-ZnuhfcNeLOLv8rfsahHDBXmgQrAdsqVbbxrHV-EW2vUK8GILaB_ehTv-mD7Fh9xFPvtxOufQer44_8ab9rqxePw7PqRs_X3HLufnv84uklhOIXECiZBUaGqo0hcaQgFlLgHZlGtUTplGJ1JBlta-lMGpWlptZVlaLYrUQq4sulECxCHbb9dtOGJc1hr9PpfVFsjnElbj4fVQOHRAQubFhH3ZEdFsBtQMswsnuzFEckMkN6k2SPIJmxGdH3oS4nXfsO5-m8hyI1SAOoAOKoPCKwFpqFxlq-DR4fISByl3XDKjDYRDNc9O_n7g5MP0aAApiTpiwuSIx6P1jZ-0zXWPzI3iT6M9dPyfa_nAXuKdGkLcTtj-tvsTPqLNs7Wf-k19D8WS_xA
  priority: 102
  providerName: Elsevier
Title Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
URI https://dx.doi.org/10.1016/j.jdcr.2017.09.007
https://www.ncbi.nlm.nih.gov/pubmed/29387762
https://pubmed.ncbi.nlm.nih.gov/PMC5789521
https://doaj.org/article/38eafea9e81a4d83a0e6c6b6ed753d77
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJCqWX0ne3j0WH3oqztiVb0jG7ZElbnJbSwFIKZvRw4pD1Ls72kH-fkWWnMZQeejHGD2mYGTHz2d-MCPlgpeQ6twhLUmMinsUmAszKoxhy0IlmsUl9vXNxmp-c8c-rbLVHsqEWpiPtG10fNlfrw6a-6LiV27WZDTyx2bdigV6mMOzM9sm-YOweRA-lwVwwkfQFMoHLdWmN7_2ZiK6naex33sMwJ4XI01E86tr2_z0sjSmT92LQ8gl53CeP9CgI-ZTsueYZeVj0v8efk19FTw-kzm_82qIZ2s22NnTtrqDZrAFPdoD54LW7pn_KpWioVaTz70dLCo2lxfEXWjcXtcbl3tJQonXzgpwtj38sTqJ--4TIMNRBlGNqITPLFTgOWSoAzZIqDEaJQtAoIYkrmwlnZCW00iLLtGI81pBKjbCJAXtJDppN414TKiqFOM8klQaPsZhWuFgtcIOAwyWWTcjHQYnlNnTJKAf62GXptV967ZexKlH7EzL3er570ne47i5s2vOyt3PJpIPKgXIyAW4lg9jlJte5swiwrMBBssFKZZ8shCQAh6r_OfmrYMm76QdPmBAxsvFIvvEddMyuE3fviG_--8235BHKJgOp7R052LW_3XvMcnZ62n0dwOOn1XxKHpwuVl9_TjtPvwWGXgEm
link.rule.ids 230,315,733,786,790,870,891,2115,3525,27957,27958,45909,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXxJvl6QM3FG0S27F97FZdbWnTA7TSHpCs8SM0Fc2u0u2Bf884ybaNhDhwi-z4oRl7Zr5kHoR89kpxW3iEJblzCRepSwCt8iSFAmxmWeryGO9cnhaLc_51KZY75GAbCxPdKgfZ38v0TloPLdOBmtN1XU-_5zGTZxYzijNUVEw9IA-50Gk82kfL2d2HllhdtwNecUASRwzBM72f16V3MS9oJrt8p7Gs7D0F1eXx_7ueGvtQ3lNK86fkyWBN0v1-w8_ITmiek0fl8L_8BflRDv6CNMRKsC3ypV2ta0evwi9oVleADxtAA_E6XNO7-CnaBy_S2bf9OYXG0_LwmNbNRW3x_re0j9n6_ZKczw_PDhbJUE8hcQyJkBRoayjhuYbAQeQSkE-5Ru2UaUSRCrK08kIGpypptZVCWM14aiFXFnEUA_aK7DarJrwhVFYagZ_LKgsRdDGr8fZ64A4RSMg8m5AvWyKadZ82w2z9yS5NJLmJJDepNkjyCZlFOt--GVNedw2r9qcZeG6YClAF0EFlwL1ikIbCFbYIHhGXlziJ2HLJjE4QTlX_c_HXPSdvl0cLSElUEhMiRzwe7W_c09QXXWpulH8aDaK3_7mXT-Tx4qw8MSdHp8fvyB72qN7f7T3Z3bQ34QMaQBv7sTvgfwCw_gJG
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUX3rQLFHzghrKbxElsH_taFUqqClGpQkjW-JE2pZtdpdsD_HomcdJuKsShtyhxHNsz9synfDNDyEcrRKIzi7AkNiZI0tAEgF55EEIGOtIsNHET75wfZQcnyZfT9HSl1FdL2je6HFeXs3FVnrfcysXMTHqe2OQ430Utk2h2JgtbTB6SR7hnY7kC1H2AcMIZj7owGc_ourCmyQAa8TazadjU30NjJzjP4oFVapP3_9s4DYmTK5Zo-pT86OfgCSi_xtdLPTZ_7qR3vNckn5EnnX9Kt32T5-SBq16Q9bz7A_-S_Mw7BiJ1TW3ZGiVdzxeloTN3CdV8BnixBHQ5r9wVvY3Ioj4cku58255SqCzN9w9pWZ2XGk-UmvoosN-vyMl0__vuQdBVaAgMwwUOMvReRGoTCS6BNOaAko8l2rtIIi4VEIWFTbkzouBaap6mWrIk1BALjciMAXtN1qp55TYJ5YVEKGmiQkMD45iWeB5YSAxiGhdZNiKfegmphU_EoXqG2oVqRKsa0apQKhTtiOw0Qrxp2STRbm_M6zPVrbJiwkHhQDoRQWIFg9BlJtOZs4jhLMdO0l4FVOePeD8Duyr_-_ENryY3n-_VbET4QIEG4xs-QbVok313avDm3m9-IOvHe1P19fPR4VvyGIcpPIXuHVlb1tduC32qpX7f7p6_v7Yh9Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple+epidermotropic+melanoma+metastases+developing+during+BRAF+and+MEK+inhibitor+therapy&rft.jtitle=JAAD+Case+Reports&rft.au=Reinhard%2C+Raphael&rft.au=Gebhardt%2C+Christoffer&rft.au=Maurier%2C+Nolwenn&rft.au=Larrib%C3%A8re%2C+Lionel&rft.date=2018-03-01&rft.issn=2352-5126&rft.eissn=2352-5126&rft.volume=4&rft.issue=2&rft.spage=129&rft.epage=131&rft_id=info:doi/10.1016%2Fj.jdcr.2017.09.007&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jdcr_2017_09_007
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-5126&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-5126&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-5126&client=summon